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Abstract: The microfilaricidal effect of ivermectin was studied on Cebus apella infected
with Dipetalonema gracile in Paraguay. Nine monkeys were treated with ivermectin at the
dosage of 200ƒÊg/kg body weight by single subcutaneous injection. The significant reduc-
tion in microfilarial count after treatment of ivermectin was recognized (P<0.01). The
change of blood picture of 9 monkeys infected with D. gracile following treatment of
ivermectin also studied. The total WBC count was found to be significantly increased at 1
day after the treatment. Differential count study showed that neutrophils increased in most
monkeys. On the other hand, the significant change in eosinophil and lymphocye count was
not observed.
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INTRODUCTION
It is well known that Cebus apella, one of the most popular monkey in the New World,
harbor Dipetalonematidae in peritoneal cavity (Yagi et al, 1986). However, little is known
about chemotherapy of this filariasis. In general, diethylcarbamazine (DEC) is widely used in
chemotherapy of human and animal filariasis, being particularly effective against microfilarae
of lymphotic filariasis due to Brugia malayi, Brugia timori and Wuchereria bancrofti.
However, DEC is not a entire drug for onchocerciasis, subcutaneous filariasis, because of it's
severe inflammatory reactions though it shows a remarkable microfilaricidal effect. On the
other hand, ivermactin, an antihelmintic drug in wide use for several years by the veterinary
industry, has recently been found to be less side effects and effective against Onchocerca
volvulus and W. bancrofti (Greene et al., 1985, Kumaraswani et al., 1988).
The present study describes the microfilaricidal effect of ivermectin and inflammatory
reactions elicited by treatment in C. apella infected with Dipetalonema gracile.
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MATERIALS AND METHODS
Twelve monkeys (3 males and 9 females), C. apella, were provided for this study. All of
them were captured in the northern part of Paraguay and maintained for more than one year
in the Laboratory of Institute of Health Science, Asuncion University. D. gracile microfilanae
were detected in all of their blood stream･ Microfilarial densities were ranged from 163 to
60,784 per O･5 ml of blood. Nine monkeys were treated with ivermectin (Merck, Sharp &
Dohme) at the dosage of 200 μg/kg body wieght by single subcutaneous injection･ Three
monkeys were given saline solution through subcutaneous as the control即oup. By the
Knott's concentration method, the number of microfilariae per O･5 ml of blood were counted
at 1, 2 days and 1, 2, 3, 4 weeks after the initial treatment (Knott, 1930)･
To know the inflammatory reaction after treatment, haematological examination was
carried out･ Total number of white blood cell (WBC) per cubic millimeter of blood was
counted by conventional method and differential cell count was assessed under giemsa stain･
ing. The blood examination was made between 9:00 and 10:00. Statistical analysis was per-
formed where appropriate using Wilcoxon's rank-sum test･
RESULTS
Table 1 shows the effect of ivermectin on the microfilarial count of D. graale. Mean
percentages of reduction on microfilarial count of trated group at 1, 2, 7, 14, 21 and 28 days
after the treatment were ･4, 37･4, 49･2, 55･7, 53.3 and 49･7% respectively･ On the other
hand, microfilarial densities of control grooup was not decreased after the injection of saline
solution. The percentage of maximum reduction in microfilarial count of each monkeys rang-





















































ed from 45.3 to lOO%. One of 9 monkeys showed the maximum reduction in microfilarial
count at 1 day after the treatment. Three monkeys showed the maximum reduction at 2 days
after the treatment. In other 5 monkeys, the maximum reduction was revealed at 1 and 2
weeks after the treatment. A significant decrease in microfilarial count was found at 1, 2, 7,
14, 21, 28 days after the treatment of ivermectin (P<0.01). The change of blood picture of 9
monkeys infected with D. gratile following treatment of ivermectin was shown in Fig. 1. The
total WBC count was found to be increased at 1 day after the treatment･ Seven of 9
monkeys showed the significant increase in total number of WBC at 1 day after the treat-
ment. The rate of increase varied from 2 to 115 percent of the initial count. On day 2 after
treatment, the total WBC count returned to the level of initial count. Differential count study
showed that neutrophils increased in 7 of 9 monkeys with the range from 52 to 425% of the
initial count at 1 day after the treatment. All monkeys with the increase of total WBC show-
ed the increase of neutrophil. The significant change in eosinophil and lymphocyte count was
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Fig. 1. Changes of blood picture following ivermectin administration.
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DISCUSSION
In this study, ivermectin were firstly tested for it's effectivenss against natural infec-
tion of D. gracile in C. apella. Nine monkeys were treated with ivermectin at a single dose of
200 jug/kg. The maximumreduction in numbers of microfilariae ranged from 45.3 to 100% of
initial level. Out of 9 monkeys, 7 showed the maximum,reduction in numbers of microfilariae
within 1 week after treatment, and these level were maintained over the next 4 weeks. Awad-
zi et al. (1985) reported that microfilarial densities fell progressively to reach their lowest
level at 1 month after the treatment of ivermectin (200 //g/kg) in patient with
onchocerciasis, and these level were maintained over next 32 weeks. Soboslay et al. (1987)
also reported that abnormal motility was observed in microfilariae in the anterior camber of
patient with onchocerciasis at 2 days after the treatment of ivermectin. Furthermore, Freed-
mannet al. (1989) reported that ivermectin was 100% effective against human ascariasis and
strongyloidiasis on 1 month after treatment.
On the other hand, diethylcarbamazice (DEC) was one of the most effective drugs
against filariasis during recent four decades. Eberhard (1982) described the marked reduction
in numbers of microfilariae of D. gracile in squirrel monkeys when treated with DEC (50
mg/kg/day for 10 days). However, the numbers of microfilariae had returned to pretreatment
level within 4 to 20 weeks. The mechanism(s) of microfilarial killing by DEC were related
to a variety of condition in host such as complement activation (Hammerberg and Staiunas,
1982), activation of granulocytes (King et al., 1983), presence of specific antibody (Sakamoto
et al, 1984), and adherence of effector cells to microfilariae (Piessens and Beldekas, 1979;
Chandrashekar et al, 1984). On the other hand, Soboslay et al (1987) suggested that ivermec-
tin directly impaired motility of microfilariae inducting spastic paralysis. In our study, it was
also suggested that rapid reduction of microfilariae was caused by direct effect of ivermectin.
The inflammatory reaction in patient with filariasis during the treatment of filaricidal
drugs have been discussed. It was generally considered that inflammatory reaction caused by
DEC administration was the result of speedy killing of microfilariae. The histological studies
showed that neutrophils, eosinophils and lymphocytes appeared in close proximity to damag-
ed microfilariae (Haqking, 1952, Gibson et al, 1976). These inflammatory reactions may in-
duce the change of blood picture of patient. Sakamoto et al (1983) reported that the total
WBC count was found to be rised in patient with onchocerciasis at 3 days after the initial
treatment of DEC. On the other hand, Awadzi et al (1985) reported that there was an in-
crease in total WBC counts after day 8, but the levels remained within the normal range.
Our study also showed that WBC cont increased (ranged from 2 to 115%) at 1 day after treat-
ment, but returned to the initial level at 2 days after treatment. The particular role of
eosinophil also have been discussed in inflammatory reaction caused by filaricidal treatment
(Bryceron, 1977; Henson et al, 1979; Guerra-Caceres et al, 1980). Money (1960) reported
that the number of eosinophil count decreased during the DEC treatment of patient with on-
chocerciasis. Guerra-Caceres et al (1980) also described the eosinopenia in patient with on-
chocerciasis at 12 hours after the treatment of DEC. When ivermectin was used for patient
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with onchocerciasis, Awadzi et al. (1985) reported that there was a slight fall in eosinophil
counts maximal at 36 hours, followed by a steady rise, so that a define increase above
pretreatment levels had occurred by day 8, and by day 28 the level was more than twice the
initial level. In our study, there was no significant change in eosinophil count during the treat-
ment of ivermectin in C. apella infected with D. gracile. Although the increase in WBC and
neutrophil counts was revealed at 1 day after treatment, the present study suggested that
ivermectin might not induce severe inflammatory reaction in C. apella infected with D.
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